IL26936A - 3-(2'chloroethoxy)-17alpha-ethynyl-17beta-hydroxy-delta1,3,5(10)-estratriene and process for the preparation thereof - Google Patents
3-(2'chloroethoxy)-17alpha-ethynyl-17beta-hydroxy-delta1,3,5(10)-estratriene and process for the preparation thereofInfo
- Publication number
- IL26936A IL26936A IL2693666A IL2693666A IL26936A IL 26936 A IL26936 A IL 26936A IL 2693666 A IL2693666 A IL 2693666A IL 2693666 A IL2693666 A IL 2693666A IL 26936 A IL26936 A IL 26936A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- estratriene
- delta1
- 17alpha
- 17beta
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 description 13
- 238000007920 subcutaneous administration Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 7
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002513 anti-ovulatory effect Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- HLCRYAZDZCJZFG-BDXSIMOUSA-N (8s,9s,13s,14s)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene Chemical compound C1CC2=CC=CC=C2[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 HLCRYAZDZCJZFG-BDXSIMOUSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- GSNKRSKIWFBWEG-UHFFFAOYSA-N 3-ethylpentan-2-one Chemical compound CCC(CC)C(C)=O GSNKRSKIWFBWEG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000002054 antogonadotrophic effect Effects 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002162 estranes Chemical class 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000000624 ovulatory effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 201000002765 pyometritis Diseases 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2643765 | 1965-11-29 | ||
| IT1998566 | 1966-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL26936A true IL26936A (en) | 1970-11-30 |
Family
ID=26327362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2693666A IL26936A (en) | 1965-11-29 | 1966-11-24 | 3-(2'chloroethoxy)-17alpha-ethynyl-17beta-hydroxy-delta1,3,5(10)-estratriene and process for the preparation thereof |
Country Status (10)
| Country | Link |
|---|---|
| AT (1) | AT268559B (enrdf_load_stackoverflow) |
| BE (1) | BE690339A (enrdf_load_stackoverflow) |
| BR (1) | BR6684878D0 (enrdf_load_stackoverflow) |
| DE (1) | DE1593465A1 (enrdf_load_stackoverflow) |
| ES (1) | ES333875A1 (enrdf_load_stackoverflow) |
| FR (1) | FR1502263A (enrdf_load_stackoverflow) |
| GB (1) | GB1100900A (enrdf_load_stackoverflow) |
| IL (1) | IL26936A (enrdf_load_stackoverflow) |
| NL (1) | NL6616084A (enrdf_load_stackoverflow) |
| SE (1) | SE303131B (enrdf_load_stackoverflow) |
-
1966
- 1966-11-15 NL NL6616084A patent/NL6616084A/xx unknown
- 1966-11-24 DE DE19661593465 patent/DE1593465A1/de active Pending
- 1966-11-24 IL IL2693666A patent/IL26936A/en unknown
- 1966-11-24 FR FR84808A patent/FR1502263A/fr not_active Expired
- 1966-11-25 BR BR18487866A patent/BR6684878D0/pt unknown
- 1966-11-25 AT AT1090066A patent/AT268559B/de active
- 1966-11-25 GB GB3500566D patent/GB1100900A/en not_active Expired
- 1966-11-28 SE SE1622866A patent/SE303131B/xx unknown
- 1966-11-28 ES ES333875A patent/ES333875A1/es not_active Expired
- 1966-11-28 BE BE690339D patent/BE690339A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6616084A (enrdf_load_stackoverflow) | 1967-05-30 |
| FR1502263A (fr) | 1967-11-18 |
| AT268559B (de) | 1969-02-10 |
| ES333875A1 (es) | 1968-03-01 |
| GB1100900A (en) | 1968-01-24 |
| SE303131B (enrdf_load_stackoverflow) | 1968-08-19 |
| DE1593465A1 (de) | 1970-07-23 |
| BE690339A (enrdf_load_stackoverflow) | 1967-05-29 |
| BR6684878D0 (pt) | 1973-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1072948A (en) | 3-OXIMES OF D-17.alpha.-ETHYNYL-19-NORTESTOSTERONE ESTERS AND METHOD | |
| DE2818164A1 (de) | 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| IL26936A (en) | 3-(2'chloroethoxy)-17alpha-ethynyl-17beta-hydroxy-delta1,3,5(10)-estratriene and process for the preparation thereof | |
| US3166473A (en) | New esters of 1, 3, 5-estratriene-3, 16, 17-triol and novel pharmaceutical compositions containing new esters of 1, 3, 5-estratriene-3, 16, 17-triol and esters of 1, 3, 5-estratriene-3, 16, 17-triol | |
| US3446823A (en) | 17alpha-ethynyl-delta**1,3,5(10)-estratriene and process for the preparation thereof | |
| DE3628189A1 (de) | Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene | |
| DE2147391B2 (de) | Verfahren zur Herstellung von 13- Äthyl-17 a -äthinyl-17 ß -hydroxy- 16 a methylgona-4-en-3-on | |
| US3313702A (en) | Estrogenic compositions comprising 17alpha-ethynyl-deta1, 3, 5(10)-estratriene-3, 11beta, 17beta-triol | |
| US2908694A (en) | 7-substituted thio-4-androstenes | |
| US3127314A (en) | Method of reducing hyperlipemia by | |
| US3442919A (en) | 17alpha - alka - 1',3' - diynyl - steroidal-4,9(10)-dien-3-ones | |
| SE324152B (enrdf_load_stackoverflow) | ||
| US3354185A (en) | 1, 2, methylene androstane derivatives | |
| DE2037155A1 (enrdf_load_stackoverflow) | ||
| SU1311217A1 (ru) | 16 @ , 17 @ -Циклогексано-17 @ -ацетил-13-метилгона-4,9-диен-3-он, про вл ющий прогестагенную активность | |
| US3147252A (en) | 16alpha, 17alpha-acetal and ketal derivatives of the pregnane series | |
| KR840000120B1 (ko) | 7α-메틸놀에틴드론 에난세이트의 제조방법 | |
| DE3144049A1 (de) | 16(beta)-methyl-8(alpha)-oestradiole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate | |
| US3390157A (en) | 3-desoxy-6alpha-methyl-17alpha-oxygenated-delta4-pregnenes | |
| US3274056A (en) | Methods for lowering blood cholesterol and compositions of alkali metal 2-methoxyestra-1, 3, 5(10)-trien-3-ol-17-one sulfate | |
| US3586669A (en) | Orally active anti-estrogenic compounds | |
| AT274256B (de) | Verfahren zur Herstellung von 3-Oxo-4,9,11-triensteroiden | |
| AT231617B (de) | Verfahren zur Herstellung von 4-Hydroxy- bzw 4-Acyloxy-17α-methyl-19-nortestosteron | |
| AT233177B (de) | Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester | |
| US3452060A (en) | 17-hydroxy-17-(3-oxo-1-propynyl or-propenyl) steroids |